This week, we bring you the story of Granules Pharmaceuticals, an Indian manufacturer of generic pharmaceuticals, which announced plans in May 2017 to invest $35 million and more than double its workforce in Fairfax County, Virginia. The company initially established a physical presence in the U.S. in 2014 with an R&D facility in Fairfax County and will soon begin manufacturing there as part of the expansion. We talked to Priyanka Chigurupati, Executive Vice President of Corporate Strategy & Business Development at Granules India Limited, and Dr. Gerald Gordon, President and CEO of the Fairfax County Economic Development Authority, for the story.